期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

转运蛋白在药物传递中的重要作用 被引量：1

下载PDF
导出
摘要 目的介绍转运蛋白在药物传递中的重要作用。方法根据文献对转运蛋白在药物传递中的重要作用进行综述。结果转运蛋白能有效地参与药物的肠吸收、分布和排泄等过程,以其为靶点可大大提高药物传递的效率,减少不良反应的发生。结论可深入地解析药物体内动态和更有效地调控药物体内行为,从而设计出安全、有效的药物及其传递系统。
作者 孙进 陆榕 范晓文 何仲贵
机构地区 沈阳药科大学药学院药剂学研究室
出处 《中国药学杂志》 CAS CSCD 北大核心 2007年第3期164-168,共5页 Chinese Pharmaceutical Journal
关键词 转运蛋白 药物传递 药物合理结构设计
分类号 R945.1 [医药卫生—微生物与生化药学]
  • 相关文献

参考文献25

  • 1孙进,孙勇兵,何仲贵.转运蛋白在药物肝胆转运中的重要作用[J].药学学报,2005,40(8):680-685. 被引量：17
  • 2高坤,孙进,何仲贵.肠道转运蛋白在药物吸收中的重要作用[J].药学学报,2006,41(2):97-102. 被引量：17
  • 3TAMAI I,NAKANISHI T,NAKAHARA H,et al.Improvement of L-Dopa absorption by dipeptidyl derivation,utilizing peptide transporter Pept1[J].J Pharm Sci,1998,87(12):1542-1546.
  • 4HU M,SUBRAMANIAN P,MOSBERG H I,et al.Use of the peptide carrier system to improve the intestinal absorption of L-α-methyldopa:carrier kinetics,intestinal permeabilities,and in vitro hydrolysis of dipeptidyl derivatives of L-α-methyldopa[J].Pharm Res,1989,6(1):66-70.
  • 5HAN H.5'-Amino acid esters of antiviral nucleosides,Acyclovir,and AZT are absorbed by the intestinal PEPTl peptide transporter[J].Pharm Res,1998,15(8):1154-1159.
  • 6CVETKOVIC M,LEAKE B,FROMM M F,et al.OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine[J].Drug Metab Dispos,1999,27(8):866～871.
  • 7HISANG B,ZHU Y,WANG Z,et al.A novel human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitors transporters[J].J Biol Chem,1999,274:37161-37168.
  • 8DRESCHER S,GLAESER H,MURDTER T,et al.P-glycoprotein-mediated intestinal and biliary digoxin transport in humans[J].Clin Pharmacol Ther,2003,73(3):223-231.
  • 9SUN J,HE Z,CHENG G,et al.Multidrug resistance P-glycoprotein:the crucial significances in drug disposition and interaction[J].Med Sci Monitor,2004,10(1):5-14.
  • 10GOTOH Y,SUZUKI H,KINOSHITA S,et al.Involvement of an organic anion transporter (canalicular multispecific organic anion transporter/mulfidrug resistance-associated protein 2) in gastrointestinal secretion of glutathione conjugates in rats[J].J Pharmacol Exp Ther,2000 292(1):433-439.

二级参考文献60

  • 1Jonker JW, Wagenaar E, Moi CA, et al. Reduced hepatic uptake and intestinal excretion of organic cations in mice with a targeted disruption of the organic cation transporter 1 ( Octl [ Slc22a1) gene[J]. Mol Cell Biol, 2001,21(16) : 5471 - 5477.
  • 2Wang DS, Jonker JW, Kato Y, et al. Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin [ J ]. J Pharmacol Exp Ther,2002,302(2) :510 - 515.
  • 3Tamai l, Yabuuchi H, Nezu Y, et al. Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1[J]. FEBS Lett, 1997,419(1) :107 -111.
  • 4Flens MJ, Zaman GJ, Van der Valk P, et al. Tissue distribution of the muhidrug resistance protein[J]. Am J Pathol, 1996,148(4) : 1237 - 1247.
  • 5Ogawa K, Suzuki H, Hirohashi T, et al. Characterization of inducible nature of Mrp3 in rat liver[J]. Am J Physiol, 2000,295 ( 3 ) : G438 - G446.
  • 6Konig J, Rost D, Cui Y, et al. Characterization of the human muhidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane[ J ].Hepatology, 1999,29(4) :1156 - 1163.
  • 7Hirohashi T, Suzuki H, Takikawa H, et al. ATP-dependent transport of bile salts by rat muhidrug resistance-associated protein ( Mrp3 ) [ J ]. J Biol Chem,2000,275 (4) : 2905 - 2910.
  • 8Thompson lL, Jansen PLM. Genetic defects in hepatocanalicular transport[ J ]. Semin Liver Dis, 2000,20(3) :365 -372.
  • 9Funk C, Ponelle C, Scheuermann G, et al. Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity, in vivo and in vitro interaction at the canalicular bile salt export pump(Bsep) in the rat [J]. Mol Pharmacol, 2001,59(3):627 - 635.
  • 10Yamazaki M, Akiyama S, Nitnuma K, et al. Biliary excretion of pravastafin in rats: contribution of the excretion pathway mediated by canalicular mulfispecific organic anion transporter[J]. Drug Metab Dispos, 1997,25(10) :1123 - 1129.

共引文献28

同被引文献32

  • 1孙进,赵焰平,郝秀华,何仲贵.多药耐药相关蛋白2:在肠道药物处置中的重要作用[J].中国新药与临床杂志,2006,25(10):792-797. 被引量：2
  • 2Endres C J, Hsiao P, Chung F S, et al. The role of transport ers in drug interactions[J]. Eur J Pharm Sci, 2006, 27 (5): 501-517.
  • 3Szakacs G, Varadi A, Ozvegy-Laezka C, et al. The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox)[J]. Drug Discov Today, 2008, 13(9 10): 379-393.
  • 4Lin JH. Drug-drug interaction mediated by inhibition and in duction of P glycoprotein[J]. Adv Drug Deliv Rev, 2003, 55 (1): 53-81.
  • 5Vallakati A, Chandra PA, Pednekar M, et al. Droncdarone Induced Digoxin Toxicity: New Drug, New Interactions[J]. Am J Ther, 2011.
  • 6Friedrich C, Ring A, Brand T, et al. Evaluation of the pharmacokinetic interaction after multiple oral doses of linagliptin and digoxin in healthy volunteers[J]. Eur J Drug Metab Phar macokinet, 2011, 36(1) : 17-24.
  • 7Shoal SE, Ohzone Y, Ninomiya S, et al. In vitro P-glycopro tein interactions and steady-state pharmacokinetie interactions between tolvaptan and digoxin in healthy subjects[J]. J Clin Pharmaeol, 2011, 51 (5) : 761-769.
  • 8Aylin Arici M, Kilinc E, Demir O, et al. Interactions between Verapamil and Digoxin in Langendorff Perfused Rat Hearts:The Role of Inhibition of P-glycoprotein in the Heart[J]. Basic Clin Pharmaeol Toxieol,2010, 107(5): 847-852.
  • 9Schmitt C, Kaeser B, Riek M, et al. Effect of saquinavir/ ritonavir on P-glycoprotein activity in healthy volunteers using digoxin as a probe[J]. Int J Clin Pharmacol Ther, 2010, 48 (3): 192-199.
  • 10Oga E F, Sekine S, Shitara Y, et al. Potential P glycoprotein mediated drug-drug interactions of antimalarial agents in Caco-2 cells[J]. Am J Trop Med Hyg, 2012, 87(1): 64-69.

引证文献1

二级引证文献10

中国药学杂志
2007年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部